301 related articles for article (PubMed ID: 33682723)
1. Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome'.
Atalaia A; Ben Yaou R; Wahbi K; De Sandre-Giovannoli A; Vigouroux C; Bonne G
J Neuromuscul Dis; 2021; 8(3):419-439. PubMed ID: 33682723
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Looking at New Unexpected Disease Targets in
Mosbah H; Vatier C; Boccara F; Jéru I; Lascols O; Vantyghem MC; Fève B; Donadille B; Sarrazin E; Benabbou S; Inamo J; Ederhy S; Cohen A; Neraud B; Richard P; Picard F; Christin-Maitre S; Redheuil A; Wahbi K; Vigouroux C
Cells; 2020 Mar; 9(3):. PubMed ID: 32245113
[TBL] [Abstract][Full Text] [Related]
4. Laminopathies: multisystem dystrophy syndromes.
Jacob KN; Garg A
Mol Genet Metab; 2006 Apr; 87(4):289-302. PubMed ID: 16364671
[TBL] [Abstract][Full Text] [Related]
5. Clinical spectrum and genetic variations of
Fan Y; Tan D; Song D; Zhang X; Chang X; Wang Z; Zhang C; Chan SH; Wu Q; Wu L; Wang S; Yan H; Ge L; Yang H; Mao B; Bönnemann C; Liu J; Wang S; Yuan Y; Wu X; Zhang H; Xiong H
J Med Genet; 2021 May; 58(5):326-333. PubMed ID: 32571898
[TBL] [Abstract][Full Text] [Related]
6. Striated muscle laminopathies.
Azibani F; Muchir A; Vignier N; Bonne G; Bertrand AT
Semin Cell Dev Biol; 2014 May; 29():107-15. PubMed ID: 24440603
[TBL] [Abstract][Full Text] [Related]
7. Laminopathies and the long strange trip from basic cell biology to therapy.
Worman HJ; Fong LG; Muchir A; Young SG
J Clin Invest; 2009 Jul; 119(7):1825-36. PubMed ID: 19587457
[TBL] [Abstract][Full Text] [Related]
8. Laminopathies and lamin-associated signaling pathways.
Maraldi NM; Capanni C; Cenni V; Fini M; Lattanzi G
J Cell Biochem; 2011 Apr; 112(4):979-92. PubMed ID: 21400569
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of fibroblasts in a family with LMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesis.
Widyastuti HP; Norden-Krichmar TM; Grosberg A; Zaragoza MV
BMC Med Genet; 2020 Jul; 21(1):152. PubMed ID: 32698886
[TBL] [Abstract][Full Text] [Related]
10. A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome.
Atalaia A; Thompson R; Corvo A; Carmody L; Piscia D; Matalonga L; Macaya A; Lochmuller A; Fontaine B; Zurek B; Hernandez-Ferrer C; Reinhard C; Gómez-Andrés D; Desaphy JF; Schon K; Lohmann K; Jennings MJ; Synofzik M; Riess O; Yaou RB; Evangelista T; Ratnaike T; Bros-Facer V; Gumus G; Horvath R; Chinnery P; Laurie S; Graessner H; Robinson P; Lochmuller H; Beltran S; Bonne G
Orphanet J Rare Dis; 2020 Aug; 15(1):206. PubMed ID: 32787960
[TBL] [Abstract][Full Text] [Related]
11. [Laminopathies: one gene, several diseases].
Bertrand AT; Chikhaoui K; Ben Yaou R; Bonne G
Biol Aujourdhui; 2011; 205(3):147-62. PubMed ID: 21982404
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype analysis of LMNA-related diseases predicts phenotype-selective alterations in lamin phosphorylation.
Lin EW; Brady GF; Kwan R; Nesvizhskii AI; Omary MB
FASEB J; 2020 Jul; 34(7):9051-9073. PubMed ID: 32413188
[TBL] [Abstract][Full Text] [Related]
13. The Cutting Edge: The Role of mTOR Signaling in Laminopathies.
Chiarini F; Evangelisti C; Cenni V; Fazio A; Paganelli F; Martelli AM; Lattanzi G
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781376
[TBL] [Abstract][Full Text] [Related]
14. Protein structural and mechanistic basis of progeroid laminopathies.
Marcelot A; Worman HJ; Zinn-Justin S
FEBS J; 2021 May; 288(9):2757-2772. PubMed ID: 32799420
[TBL] [Abstract][Full Text] [Related]
15. Non-syndromic cardiac progeria in a patient with the rare pathogenic p.Asp300Asn variant in the LMNA gene.
Marian AJ
BMC Med Genet; 2017 Oct; 18(1):116. PubMed ID: 29047356
[TBL] [Abstract][Full Text] [Related]
16. In Silico and In Vivo Analysis of Amino Acid Substitutions That Cause Laminopathies.
Hinz BE; Walker SG; Xiong A; Gogal RA; Schnieders MJ; Wallrath LL
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681887
[TBL] [Abstract][Full Text] [Related]
17. Lipodystrophic laminopathies: Diagnostic clues.
Guillín-Amarelle C; Fernández-Pombo A; Sánchez-Iglesias S; Araújo-Vilar D
Nucleus; 2018 Jan; 9(1):249-260. PubMed ID: 29557732
[TBL] [Abstract][Full Text] [Related]
18. Systematic identification of pathological lamin A interactors.
Dittmer TA; Sahni N; Kubben N; Hill DE; Vidal M; Burgess RC; Roukos V; Misteli T
Mol Biol Cell; 2014 May; 25(9):1493-510. PubMed ID: 24623722
[TBL] [Abstract][Full Text] [Related]
19. Need for NAD
Cardoso D; Muchir A
Cells; 2020 Oct; 9(10):. PubMed ID: 33036437
[TBL] [Abstract][Full Text] [Related]
20. [Laminopathies: lipodystrophies, insulin resistance, syndromes of accelerated ageing... and others].
Vigouroux C
Ann Endocrinol (Paris); 2005 Jun; 66(3):270-8. PubMed ID: 15988390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
